{"id":779532,"date":"2025-12-31T14:10:26","date_gmt":"2025-12-31T13:10:26","guid":{"rendered":"https:\/\/www.hashtag.al\/?p=779532"},"modified":"2025-12-31T14:10:26","modified_gmt":"2025-12-31T13:10:26","slug":"prodhuesit-e-barnave-rrisin-cmimet-ne-shba-per-350-ilace-pavaresisht-presionit-nga-trump","status":"publish","type":"post","link":"https:\/\/www.hashtag.al\/index.php\/2025\/12\/31\/prodhuesit-e-barnave-rrisin-cmimet-ne-shba-per-350-ilace-pavaresisht-presionit-nga-trump\/","title":{"rendered":"Prodhuesit e barnave rrisin \u00e7mimet n\u00eb SHBA p\u00ebr 350 ila\u00e7e, pavar\u00ebsisht presionit nga Trump","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"

\"\"<\/span><\/p>\n

Prodhuesit e barnave planifikojn\u00eb t\u00eb rrisin \u00e7mimet n\u00eb SHBA p\u00ebr t\u00eb pakt\u00ebn 350 ila\u00e7e t\u00eb markuara, p\u00ebrfshir\u00eb vaksina kund\u00ebr COVID-19, RSV dhe herpesit, si edhe trajtimin e njohur kund\u00ebr kancerit Ibrance<\/em>, pavar\u00ebsisht presionit nga administrata e Donald Trump p\u00ebr ulje \u00e7mimesh, sipas t\u00eb dh\u00ebnave t\u00eb ofruara ekskluzivisht nga firma k\u00ebrkimore n\u00eb sh\u00ebndet\u00ebsi 3 Axis Advisors<\/em>.<\/span><\/p>\n

Numri i rritjeve t\u00eb \u00e7mimeve p\u00ebr vitin 2026 \u00ebsht\u00eb m\u00eb i lart\u00eb krahasuar me t\u00eb nj\u00ebjt\u00ebn periudh\u00eb t\u00eb vitit t\u00eb kaluar, kur kompanit\u00eb farmaceutike kishin paralajm\u00ebruar rritje p\u00ebr m\u00eb shum\u00eb se 250 barna. Rritja mesatare e \u00e7mimeve k\u00ebt\u00eb vit \u00ebsht\u00eb rreth 4 p\u00ebr qind, n\u00eb linj\u00eb me vitin 2025.<\/span><\/p>\n

K\u00ebto rritje nuk pasqyrojn\u00eb zbritjet q\u00eb u jepen menaxher\u00ebve t\u00eb p\u00ebrfitimeve farmaceutike apo skemat e tjera t\u00eb diskontimit.<\/span><\/p>\n

Nd\u00ebrkoh\u00eb, disa kompani planifikojn\u00eb edhe ulje \u00e7mimesh p\u00ebr nj\u00eb num\u00ebr t\u00eb kufizuar barnash.<\/span><\/p>\n

Rreth n\u00ebnt\u00eb ila\u00e7e pritet t\u00eb p\u00ebsojn\u00eb ulje, p\u00ebrfshir\u00eb nj\u00eb ulje mbi 40 p\u00ebr qind p\u00ebr ila\u00e7in kund\u00ebr diabetit Jardiance<\/em> t\u00eb kompanis\u00eb Boehringer Ingelheim<\/em> dhe tre trajtime t\u00eb lidhura me t\u00eb. Boehringer Ingelheim<\/em> dhe Eli Lilly<\/em>, q\u00eb e tregtojn\u00eb bashk\u00eb Jardiance<\/em>, nuk kan\u00eb dh\u00ebn\u00eb menj\u00ebher\u00eb komente p\u00ebr arsyet e k\u00ebtyre uljeve.<\/span><\/p>\n

Jardiance<\/em> \u00ebsht\u00eb nj\u00eb nga 10 barnat p\u00ebr t\u00eb cilat qeveria amerikane ka negociuar nj\u00eb \u00e7mim m\u00eb t\u00eb ul\u00ebt p\u00ebr programin Medicare<\/em> p\u00ebr personat mbi 65 vje\u00e7, duke nisur nga viti 2026. N\u00eb kuad\u00ebr t\u00eb k\u00ebtyre negociatave, Boehringer<\/em> dhe Lilly<\/em> e ul\u00ebn \u00e7mimin e Jardiance<\/em> me rreth dy t\u00eb tretat.<\/span><\/p>\n

Pacient\u00ebt amerikan\u00eb aktualisht paguajn\u00eb shum\u00eb m\u00eb tep\u00ebr p\u00ebr barnat me recet\u00eb sesa qytetar\u00ebt e vendeve t\u00eb tjera t\u00eb zhvilluara, shpesh gati trefishin e \u00e7mimeve.<\/span><\/p>\n

Donald Trump ka ushtruar presion mbi kompanit\u00eb farmaceutike q\u00eb t\u2019i ulin \u00e7mimet n\u00eb nivele t\u00eb krahasueshme me ato q\u00eb paguajn\u00eb pacient\u00ebt n\u00eb vende me nivel t\u00eb ngjash\u00ebm zhvillimi ekonomik.<\/span><\/p>\n

Rritjet e \u00e7mimeve p\u00ebr 350 barna po ndodhin edhe pse Trump ka arritur marr\u00ebveshje me 14 kompani farmaceutike p\u00ebr \u00e7mimet e disa ila\u00e7eve n\u00eb kuad\u00ebr t\u00eb programit Medicaid<\/em> p\u00ebr amerikan\u00ebt me t\u00eb ardhura t\u00eb ul\u00ebta dhe p\u00ebr blerjet direkte me para n\u00eb dor\u00eb. Pfizer<\/em>, Sanofi<\/em>, Boehringer Ingelheim<\/em>, Novartis<\/em> dhe GSK<\/em> jan\u00eb mes k\u00ebtyre kompanive dhe gjithashtu planifikojn\u00eb rritje \u00e7mimesh p\u00ebr disa barna q\u00eb nga 1 janari.<\/span><\/p>\n

\u201cK\u00ebto marr\u00ebveshje po paraqiten si transformuese, kur n\u00eb fakt ato vet\u00ebm sa prekin sip\u00ebrfaq\u00ebsisht problemin real q\u00eb nxit \u00e7mimet e larta t\u00eb barnave me recet\u00eb n\u00eb SHBA,\u201d<\/em> tha Dr. Benjamin Rome<\/em>, studiues i politikave sh\u00ebndet\u00ebsore n\u00eb spitalin Brigham and Women\u2019s<\/em> n\u00eb Boston.<\/span><\/p>\n

Sipas tij, kompanit\u00eb duket se po maksimizojn\u00eb \u00e7mimet, nd\u00ebrsa paralelisht negociojn\u00eb zbritje me siguruesit sh\u00ebndet\u00ebsor\u00eb dhe farmaceutik\u00eb, p\u00ebr t\u00eb vendosur m\u00eb pas nj\u00eb \u00e7mim tjet\u00ebr p\u00ebr shitjet direkte tek konsumatori.<\/span><\/p>\n

Nj\u00eb z\u00ebdh\u00ebn\u00ebs i Departamentit amerikan t\u00eb Sh\u00ebndet\u00ebsis\u00eb (HHS<\/em>) refuzoi t\u00eb komentoj\u00eb.<\/span><\/p>\n

N\u00eb vitet e fundit, kompanit\u00eb farmaceutike kan\u00eb frenuar rritjet e forta t\u00eb \u00e7mimeve, pas kritikave t\u00eb ashpra nga ligjv\u00ebn\u00ebsit dhe politikave t\u00eb reja qeveritare, p\u00ebrfshir\u00eb penalizimin e kompanive q\u00eb rrisin \u00e7mimet p\u00ebr Medicare<\/em> m\u00eb shpejt se inflacioni.<\/span><\/p>\n

Pfizer<\/em> ka njoftuar numrin m\u00eb t\u00eb madh t\u00eb rritjeve, p\u00ebr rreth 80 barna t\u00eb ndryshme, p\u00ebrfshir\u00eb Ibrance<\/em>, ila\u00e7in kund\u00ebr migren\u00ebs Nurtec<\/em>, trajtimin kund\u00ebr COVID-19 Paxlovid<\/em>, si edhe disa barna q\u00eb p\u00ebrdoren n\u00eb spitale, si morfina dhe hidromorfoni.<\/span><\/p>\n

Shumica e rritjeve t\u00eb Pfizer<\/em> jan\u00eb n\u00ebn 10 p\u00ebr qind, me p\u00ebrjashtim t\u00eb nj\u00eb rritjeje prej 15 p\u00ebr qind p\u00ebr vaksin\u00ebn kund\u00ebr COVID-19 Comirnaty<\/em>, nd\u00ebrsa disa barna spitalore me \u00e7mim t\u00eb ul\u00ebt p\u00ebsuan rritje mbi kat\u00ebrfish.<\/span><\/p>\n

N\u00eb nj\u00eb deklarat\u00eb, Pfizer<\/em> tha se kishte p\u00ebrshtatur \u00e7mimin mesatar t\u00eb list\u00ebs p\u00ebr barnat dhe vaksinat e saj inovative p\u00ebr vitin 2026 n\u00ebn norm\u00ebn e p\u00ebrgjithshme t\u00eb inflacionit.<\/span><\/p>\n

\u201cKjo rritje modeste \u00ebsht\u00eb e nevojshme p\u00ebr t\u00eb mb\u00ebshtetur investimet q\u00eb na lejojn\u00eb t\u00eb vazhdojm\u00eb zbulimin dhe ofrimin e barnave t\u00eb reja, si edhe p\u00ebr t\u00eb p\u00ebrballuar rritjen e kostove n\u00eb t\u00eb gjith\u00eb aktivitetin ton\u00eb,\u201d<\/em> thuhet n\u00eb deklarat\u00eb.<\/span><\/p>\n

Kompania europiane GSK<\/em> planifikon t\u00eb rris\u00eb \u00e7mimet p\u00ebr rreth 20 barna dhe vaksina, me rritje q\u00eb variojn\u00eb nga 2 p\u00ebr qind deri n\u00eb 8.9 p\u00ebr qind, duke theksuar se k\u00ebto rritje jan\u00eb t\u00eb nevojshme p\u00ebr t\u00eb mb\u00ebshtetur inovacionin shkencor. Sanofi<\/em> dhe Novartis<\/em> nuk iu p\u00ebrgjigj\u00ebn k\u00ebrkesave p\u00ebr koment.<\/span><\/p>\n

Sipas Reuters<\/em><\/a><\/span>, m\u00eb shum\u00eb rritje dhe ulje \u00e7mimesh pritet t\u00eb shpallen n\u00eb fillim t\u00eb janarit, i cili historikisht \u00ebsht\u00eb muaji kryesor kur kompanit\u00eb farmaceutike rrisin \u00e7mimet e barnave n\u00eb SHBA.<\/span><\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"excerpt":{"rendered":"

Prodhuesit e barnave planifikojn\u00eb t\u00eb rrisin \u00e7mimet n\u00eb SHBA p\u00ebr t\u00eb pakt\u00ebn 350 ila\u00e7e t\u00eb markuara, p\u00ebrfshir\u00eb vaksina kund\u00ebr COVID-19, RSV dhe herpesit, si edhe trajtimin e njohur kund\u00ebr kancerit Ibrance, pavar\u00ebsisht presionit nga administrata e Donald Trump p\u00ebr ulje \u00e7mimesh, sipas t\u00eb dh\u00ebnave t\u00eb ofruara ekskluzivisht nga firma k\u00ebrkimore n\u00eb sh\u00ebndet\u00ebsi 3 Axis Advisors. […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":32,"featured_media":779533,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53],"tags":[],"class_list":["post-779532","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fast-foodi"],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts\/779532","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/comments?post=779532"}],"version-history":[{"count":99999,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts\/779532\/revisions"}],"predecessor-version":[{"id":779534,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts\/779532\/revisions\/779534"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/media\/779533"}],"wp:attachment":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/media?parent=779532"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/categories?post=779532"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/tags?post=779532"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}